Waters Corporation 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Waters Corporation on December 9, 2016. The report details corporate governance actions taken by the Compensation Committee of the Board of Directors regarding executive compensation under the Waters Corporation 2012 Equity Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the approval of equity awards and does not contain financial performance data.
Material Changes
The primary material event reported is the approval of Performance Stock Unit (PSU) awards for three executive officers. The awards are contingent on the Company's total shareholder return relative to the S&P 500 Health Care Index over a three-year period. The number of shares issuable can range from 0% to 200% of the target award based on performance goals.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the inherent performance conditions of the equity awards. The vesting of the granted PSUs is subject to the achievement of specific shareholder return targets.
Important Facts for Investors
- Executive Awards: PSUs were granted to Christopher J. O'Connell (CEO), Mark T. Beaudouin (SVP, General Counsel), and Elizabeth B. Rae (SVP, Global Human Resources).
- Grant Sizes: Target awards were 10,752 shares for the CEO, 2,365 for the General Counsel, and 2,150 for the SVP of Human Resources.
- Performance Conditions: Vesting is tied to a three-year total shareholder return comparison against the S&P 500 Health Care Index.
- Maximum Payout: Executives may receive up to 200% of the target number of shares if performance goals are exceeded.